<DOC>
	<DOCNO>NCT02915718</DOCNO>
	<brief_summary>Dilated cardiomyopathy ( DCM ) cause significant morbidity mortality third common cause heart failure frequent reason heart transplantation . The etiology dilate cardiomyopathy ( DCM ) complex . There grow body literature suggest humoral immune system activation autoantibodies myocardial generation play important role progression DCM . At present immunoadsorption technology successfully apply autoimmune antibody removal treatment variety disease . And application immunoadsorption ( IA ) patient DCM show immunoadsorption ( IA ) indeed reduce autoantibody , improve symptom prognosis , additional research need identify indication instrument IA treatment DCM .</brief_summary>
	<brief_title>A Clinical Study Immunoadsorption Therapy Dilated Cardiomyopathy</brief_title>
	<detailed_description>40 patient randomly divide 2 groups： experimental group control group experimental group： Device : protein A immunoadsorption protein-A immunoadsorption 5 day i.v . ( intravenous injection ) IgG ( Immunoglobulin G）（0.5g/kg Body weight） substitution control group： non intervention</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Dilated cardiomyopathy LVEF &lt; = 40 % determine contrast echocardiography NYHA ( New York Heart Association ) class II IV Age 1870 Disease duration : symptomatic heart failure ≥ 6 month prior screen date Treatment AngiotensinConverting Enzyme inhibitor ( ACEI ) angiotensin II receptor blocker ( ARB ) , betablockers , aldosterone antagonist ( latter discretion attend physician ) , least 6 month stable dos least 2 month prior screen date . β1 adrenergic receptor antibody positive The patient 's informed consent NYHA class IV patient bedridden dependent upon parenteral medication Cardiac insufficiency result another basic disease ( e.g . coronary artery disease , ≥50 % stenosis major vessel ascertain coronary angiography perform recent three year screen date , hypertensive heart disease , valvular defect &gt; second degree History myocardial infarction Acute myocarditis accord Dallas criterion Endocrine disorder exclude insulindependent diabetes mellitus Implanted cardiac defibrillator ( ICD ) &lt; 1 month screen date Cardiac resynchronization therapy ( CRT ) &lt; 6 month screen date I.v . medication inotropic drug , vasodilator repeat ( &gt; 1/day ) i.v . administration diuretic . Active infectious disease , sign ongoing infection Creactive protein ( CRP ) &gt; 10mmol/L Impaired renal function ( serum creatinine &gt; 220 µmol/L ) Any disease require immunosuppressive drug Anaemia ( haemoglobin 90 g/L ) due cause congestive heart failure ( CHF ) Pregnancy lactation , childbearing potential without appropriate contraception Alcohol drug abuse Presence malignant tumour , remission malignancy &lt; 5 year Refusal patient provide consent Suspected poor capability follow instruction cooperate Another lifethreatening disease poor prognosis ( survival less 2 year ) Participation clinical study within less 30 day prior screen date Previous treatment IA immunoglobulin Contraindications application echocardiography contrast agent use ( accordance product specification ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dilate cardiomyopathy</keyword>
	<keyword>immunoadsorption</keyword>
</DOC>